Skip to main content
. 2026 Sep 9;62(9):1732. doi: 10.3390/medicina62091732
CONUT Controlling nutritional status
FOLFIRINOX Fluorouracil, leucovorin, irinotecan, and oxaliplatin
OS Overall survival
PFS Progression-free survival
RECIST Response evaluation criteria in solid tumors
ECOG PS Eastern cooperative oncology group performance status
BMI Body mass index
CEA Carcinoembryonic antigen